 |
 |

Advanced Alzheimer's Disease Is a Risk Factor for Late-Onset Seizures
Matthew F. Romanelli, MD;
John C. Morris, MD;
Kenneth Ashkin, MD;
Lawrence A. Coben, MD
Arch Neurol. 1990;47(8):847-850.
Abstract
 |  |
To determine the role of Alzheimer's disease as a causative factor for lateonset epilepsy, 44 subjects with mild senile dementia of the Alzheimer type and 58 healthy control subjects were examined over a 90-month period for the development of focal or generalized seizure activity (excluding myoclonus). At entry, all subjects were free of prior seizures and other neurologic, medical, and psychiatric disorders with the potential to impair cognition. Although no control subject developed seizures during the study period, 7 subjects with senile dementia of the Alzheimer type had at least one documented seizure. All 7 subjects had progressed to the severe stage of dementia by the time of the first seizure. Seizures were generalized tonic-clonic in type and were unassociated with clinical or (in 3 subjects) neuropathologic evidence for epileptogenic factors other than Alzheimer's disease. We conclude that advanced Alzheimer's disease alone may be an important risk factor for new-onset seizures in older adults.
Author Affiliations
From the Departments of Neurology and Neurosurgery (Neurology) (Drs Morris and Coben) and Pathology (Neuropathology) (Dr Morris) and the Alzheimer's Disease Research Center (Drs Romanelli, Morris, Ashkin, and Coben), Washington University School of Medicine, St Louis, Mo. Dr Romanelli is now with the Department of Psychiatry, Stony Brook (NY) University Hospital, and Dr Ashkin is with the Department of Neurology, Neurological Institute, New York, NY.
Footnotes
Accepted for publication January 9, 1990.
Reprint requests to Alzheimer's Disease Research Center, Box 8111, Washington University School of Medicine, 660 S Euclid Ave, St Louis, MO 63110 (Dr Morris).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Seizures in Alzheimer Disease: Who, When, and How Common?
Scarmeas et al.
Arch Neurol 2009;66:992-997.
ABSTRACT
| FULL TEXT
Distinctive roles of different {beta}-amyloid 42 aggregates in modulation of synaptic functions
Chiang et al.
FASEB J. 2009;23:1969-1977.
ABSTRACT
| FULL TEXT
Epilepsy and Cognitive Impairments in Alzheimer Disease
Palop and Mucke
Arch Neurol 2009;66:435-440.
ABSTRACT
| FULL TEXT
Levetiracetam for managing neurologic and psychiatric disorders
Farooq et al.
Am J Health Syst Pharm 2009;66:541-561.
ABSTRACT
| FULL TEXT
Monotherapy with Lamotrigine in patients with Alzheimer's disease and seizures
Tsolaki et al.
AM J ALZHEIMERS DIS OTHER DEMEN 2000;15:74-79.
ABSTRACT
Seizures and Epilepsy in the Elderly
Thomas
Arch Intern Med 1997;157:605-617.
ABSTRACT
Seizures in Alzheimer's Disease: Clinicopathologic Study
Mendez et al.
J Geriatr Psychiatry Neurol 1994;7:230-233.
ABSTRACT
Neurologic Signs in Alzheimer's Disease: Results of a Prospective Clinical and Neuropathologic Study
Forstl et al.
Arch Neurol 1992;49:1038-1042.
ABSTRACT
Geriatric Epilepsy: A Review
Sanders and Murray
J Geriatr Psychiatry Neurol 1991;4:98-105.
ABSTRACT
|